Regen BioPharma Inc
OTC:RGBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regen BioPharma Inc
OTC:RGBP
|
US |
|
IQ-AI Ltd
LSE:IQAI
|
JE |
|
Ace Hardware Indonesia Tbk PT
OTC:ACEHF
|
ID |
|
S
|
Siili Solutions Oyj
LSE:0RFO
|
FI |
|
Sartorius AG
OTC:SARTF
|
DE |
|
Chengdu Expressway Co Ltd
HKEX:1785
|
CN |
|
A
|
Atalaya Mining PLC
LSE:ATYM
|
CY |
|
VisasQ Inc
TSE:4490
|
JP |
|
Marimekko Oyj
OTC:MKKOF
|
FI |
|
Eurazeo SE
PAR:RF
|
FR |
|
Field Trip Health Ltd
TSX:FTRP
|
CA |
|
R
|
Reply SpA
SWB:REJA
|
IT |
|
L
|
Lyckegard Group AB
F:F55
|
SE |
|
L
|
Lexington Biosciences Holdings Corp
OTC:LXGTF
|
CA |
|
T
|
Tibet Water Resources Ltd
HKEX:1115
|
HK |
|
Goldpac Group Ltd
HKEX:3315
|
HK |
|
N
|
Neto ME Holdings Ltd
TASE:NTO
|
IL |
Bankruptcy Probability
Regen BioPharma Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Regen BioPharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Regen BioPharma Inc
OTC:RGBP
|
77.7k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Regen BioPharma Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Regen BioPharma Inc has total debt of 132.5k USD. This includes both short-term (132.5k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
